THE PREVENTIVE SYSTEM IN THE EDUCATION OF THE YOUNG By St. Don Bosco

THE PREVENTIVE SYSTEM IN THE EDUCATION OF THE YOUNG

CRITICAL EDITION: P. BRAIDO - TRANSLATION & NOTES: P. LAWS

INTRODUCTION

On March 12, 1877, there took place the solemn opening in new quarters of the Patronage de Saint

Pierre, St Peter's Youth Centre, at Nice. Don Bosco gave the occasional address. For many reasons it was important that the event should go well; for this reason, Don Bosco took as his subject-matter his system of education, to which he had begun to give the title "Preventive".

Upon Don Bosco's return to Turin, he had his address written up in more polished form, with also a French translation: he had spoken on the occasion itself in a mixture of Italian and French. It underwent various re-editings. Originally published together with the account of the solemn opening - it began life essentially as a propaganda document - it eventually acquired a life of its own, representing as it does Don Bosco's only attempt at setting out his educational principles in systematic form.

The translation is based on Braido's 'Document R', which contains later refinements to the text, and which was printed together with the Regulations For The Houses Of The Society Of St Francis Of Sales, in 1877.

TEXT

Flax Seed Meal--- the best thing to add to your diet!

 Essential Fatty Acids (EFA).  Remember, in nutrition the word “essential” means it’s not made in the body so it must be obtained in the diet or supplementally.  EFA’S are genetically active and in fact have been shown to reduce the incidences of several genetically dependent cancers.  Specifically forms of both prostate and breast cancer were genetically modified creating reductions in their incidence when subjects were given Omega-3 fatty acids from fish.  Other studies have demonstrated the effects of dietary fats on liver genes.  So clearly appropriate fat intake is an important part of genetic health. 

Omega-3

One cheap source can be found in flax seed meal, which I think is a better source than flax seed oil, because it doesn't go rancid fast like oil. One tablespoon of flax seed meal has 10 times more potential Omega-3 than most fish oil capsules. It doesn't give Omega-3 directly but the body processes it to become Omega-3 and Omega-6(another EFA) from a chemical alpha linolenic acid (ALA).

Mercury in fillings and in some Vaccines

Mercury in fillings and in some Vaccines was used years ago as an disinfectant and preservative.  The element mercury is an ingredient in dental amalgams, now being phased out. Some vaccines, since the 1930s, have contained the preservative thiomersal, which is metabolized or degraded to ethyl mercury. Thiomersal has been removed from or reduced to trace amounts in all U.S. vaccines recommended for children 6 years of age and under, with the exception of inactivated influenza vaccine.link But even trace amounts are extremely dangerous if injected directly into the blood stream as seen in the video below:

Hope for Alzheimer's disease: Drug used to treat athlete's foot 'slows down Alzheimer's'

[update 6-5- 2012--see new hope for Alzheimer's   in this post very exciting!]

[editor: This article is a little old but it is worth reading and asking about the progress in this treatment to health professionals. Drinking smoothies 3 times a week with some cilantro has been suggested to help remove heavy metals that may collect in the body and brain. Heavy metal retention in the body has also been connected to other nerve dysfunctions like multiple sclerosis. The main problem with this treatment is the drug "clioquinol" in in public domain and can't be patented---- ]

Drug used to treat athlete's foot 'slows down Alzheimer's'

By Michael Day and Martyn Halle

http://www.telegraph.co.uk/news/uknews/1451367/Drug-used-to-treat-athletes-foot-slows-down-Alzheimers.html 

12:01AM GMT 11 Jan 2004

A drug that is used in the treatment of athlete's foot could be used to treat Alzheimer's disease, according to a new study by British doctors.

The study, by a team from University College, London, found that clioquinol, a drug that is also used to treat ear infections and indigestion, can almost halt the progression of Alzheimer's.

It discovered that clioquinol, which was developed 100 years ago, is able to absorb the zinc and copper atoms that concentrate in the brains of Alzheimer's sufferers before dementia sets in.

Doctors believe that by absorbing these atoms, clioquinol can arrest the onset of dementia, potentially helping thousands of people.

Dr Craig Ritchie, a psychiatrist at UCL and a Medical Research Council research fellow who led the trial, said that the results were "very exciting".

"The patients on this trial had Alzheimer's that was mild to moderate, but there was very little change in their brains once they had started treatment," he said.
"This drug could give your mind a chance to stay healthy as long as your body does. Particularly for patients who get this terrible disease in middle age, we need better treatments."

The study was prompted by research at Melbourne University in Australia and Harvard University in the United States, which found that clioquinol could prevent zinc from building up on the surface of the brain.
Academics from the universities speculated that by blocking zinc they could halt, and possibly reduce, the brain damage that causes Alzheimer's victims to lose their memory.

To test their theory, the UCL doctors tested 13 Alzheimer's patients, giving them clioquinol over a nine-month period, and 13 other Alzheimer's sufferers who were given a placebo.

The results, published in the Archives of Neurology, show that patients given clioquinol retained significantly more mental capacity than those who received the placebos. Dr Ritchie said that the patients taking clioquinol experienced a decline in their mental faculties of just 1.4 per cent.

"You would normally see a drop of four points or more in someone with Alzheimer's over the period of time we treated these patients," he added. "For those taking the placebo, their mental decline was 8.9 per cent. It's a very large gap and indicated that the drug was working."

Alzheimer's affects one in 10 people over the age of 65, and almost half of those aged 85 and over.

The protective effect of clioquinol appears to be nearly twice as great as that of the latest generation of Alzheimer's drugs, such as donepezil, which are expensive and not always widely available.

A survey by Pfizer, the drug company, revealed last week that the availability of treatments, which cost up to £100 a month, varied sharply across Britain. In the worst area, Lothian in Scotland, less than £1 a head was spent on these drugs in the over-65 population compared with more than £10 a head in Northern Ireland.
Clioquinol should be much cheaper because it is no longer protected by a patent.
Prana Technology, an Australian drug firm, provided clioquinol for the first small trial. Larger trials of the drug are expected to start shortly and will include British patients.

Dr Ritchie said that animal studies had suggested that the drug might even reverse the progress of the dementia - something that current treatments are unable to do.
"We know that in mice the disease was reversed. Everyone is excited but this was only a small trial and we have to do a larger trial. We think this drug will produce the same results in extended trials with humans. If we can get to them early, we might be able to treat patients and leave them with very little damage to their brain."

One fear over the long-term use of clioquinol is that it may damage peripheral nerves and the nerves in the eye. Dr Ritchie said his team found no evidence of this during their trial.

Dr Susanne Sorensen, the head of research at the Alzheimer's Society, said: "The UCL research suggests that there may be a novel use for this already existing drug in the treatment of Alzheimer's disease. But the trial is limited in its scale and we believe it would be valuable to see a larger scale trial.

"The potential for new drugs that may interfere with or revert the progression of Alzheimer's disease gives hope to people with dementia and their carers."
The plight of sufferers and their carers was brought home to millions two years ago when the film biography of the novelist Iris Murdoch was showered with awards for its touching and realistic portrayal of the writer's dementia.

Vaccines, Neurodevelopment and Autism Spectrum Disorders

Vaccines, Neurodevelopment and Autism Spectrum Disorders
http://www.russellblaylockmd.com/

The Danger of Excessive Vaccination During Brain Development: The Case for a Link to Autism Spectrum Disorders


Russell L. Blaylock, M.D.

[Russell Blaylock, M.D. not only compiles and edits Newsmax.com's Blaylock Wellness Report. He's also a nationally recognized board-certified neurosurgeon, health practitioner, author and lecturer.

He attended the Louisiana State University School of Medicine in New Orleans and completed his internship and neurosurgical residency at the Medical University of South Carolina in Charleston. For over a quarter of a century, he practiced in the demanding field of neurosurgery in addition to having a nutritional practice.

He recently retired from his neurosurgical duties to devote his full attention to nutritional studies and research. Dr. Blaylock is the 2004 recipient of the Integrity in Science Award granted by the Weston A. Price Foundation. He serves on the editorial staff of the Journal of the American Nutraceutical Association and is a member of the editorial board of the Journal of American Physicians and Surgeons, official publication of the Association of American Physicians and Surgeons.

He previously served as Clinical Assistant Professor of Neurosurgery at the University of Mississippi Medical Center in Jackson, MS, and is currently a visiting professor of biology at the Belhaven College, also in Jackson.]


In 1976, children received 10 vaccines before attending school. Today they will receive over 36 injections. The American Academy of Pediatrics and the Center for Disease Control assured parents that it was safe to not only give these vaccines, but that they could be given at one time with complete safety. Is this true? Or are we being lied to on a grand scale?

The medical establishment has created a set of terms, which they use constantly to boost their egos and firm up their authority as the unique holders of medical wisdom–the mantra is “evidence-based medicine”, as if everything outside their anointing touch is bogus and suspect. A careful examination of many of the accepted treatments reveals that most have little or no scientific “evidence-based” data to support it. One often repeated study found that almost 80% of medical practice had no scientific backing.

This is not to say that medical practice should be purely based on pure and applied science, as understood in the fields of physics and chemistry. Medicine, as pointed out by many of the great men of medicine, is an art. For a discussion on the proper role of medicine I refer the reader to my paper titled –Regimentation in Medicine and the Death of Creativity – on my website (www.russellblaylockmd.com).

Most men of medicine recognize that some things are obvious without a placebo controlled, double-blind, randomized study. For example, there has never been such a study to see if smashing your finger with a hammer will be painful, but we accept it without such pristine evidence. The same is true with removing brain tumors or sewing up severe lacerations.

I find it interesting that there exist an incredible double standard when it comes to our evidence versus theirs.

Merry Gentleman

Help Yourself get Organized

Here are some particle tips on organizing your day:

I’ve been working for sometime to find what works for me. Kelly and Oliver invited me to share my decidedly low-tech system which, for me, meets all of Kelly’s criteria…

I learned of GTD about six years ago via a blogging buddy in the manufacturing world. I devoured “Getting Things Done” and tried to apply it. I saw some success yet struggled to find a list manager to capture all the “stuff” coming my way.

http://www.gtdtimes.com/2008/04/28/a-simple-index-card-gtd-system/